Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-05

FDA Approved: SPIRONOLACTONE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the original ANDA for spironolactone from Amneal Pharmaceuticals NY LLC, enabling a generic version of the diuretic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

ORIG AP for SPIRONOLACTONE (SPIRONOLACTONE)